<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2019//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_190101.dtd">
<PubmedArticleSet>
<PubmedArticle>
    <MedlineCitation Status="MEDLINE" Owner="NLM">
        <PMID Version="1">27409669</PMID>
        <DateCompleted>
            <Year>2018</Year>
            <Month>01</Month>
            <Day>12</Day>
        </DateCompleted>
        <DateRevised>
            <Year>2018</Year>
            <Month>11</Month>
            <Day>13</Day>
        </DateRevised>
        <Article PubModel="Print">
            <Journal>
                <ISSN IssnType="Electronic">1949-2553</ISSN>
                <JournalIssue CitedMedium="Internet">
                    <Volume>7</Volume>
                    <Issue>32</Issue>
                    <PubDate>
                        <Year>2016</Year>
                        <Month>08</Month>
                        <Day>09</Day>
                    </PubDate>
                </JournalIssue>
                <Title>Oncotarget</Title>
                <ISOAbbreviation>Oncotarget</ISOAbbreviation>
            </Journal>
            <ArticleTitle>sTLR4/MD-2 complex inhibits colorectal cancer in vitro and in vivo by targeting LPS.</ArticleTitle>
            <Pagination>
                <MedlinePgn>52032-52044</MedlinePgn>
            </Pagination>
            <ELocationID EIdType="doi" ValidYN="Y">10.18632/oncotarget.10496</ELocationID>
            <Abstract>
                <AbstractText>Colorectal cancer (CRC) is aggressive and associated with TLR4-MD-2 signaling. Toll-like receptor 4 (TLR4) and myeloid differentiation protein 2 (MD-2) were highly expressed in human CRC. The soluble form of extracellular TLR4 domain (sTLR4) and MD-2 may have important roles in binding lipopolysaccharide (LPS). In this study, sTLR4 and MD-2 protein and prepared sTLR4/MD-2 complex were synthesized successfully to restrain LPS-TLR4/MD-2 activation by competing with cellular membrane TLR4 for binding LPS. The sTLR4/MD-2 complex can significantly attenuate LPS induced pro-inflammatory and migration cytokine production in vitro and in vivo, and inhibit the effect of LPS on the cell cycle, migration and invasion of human CRC cells in vitro. Administration of sTLR4/MD-2 complex protected mice from tumor both in xenograft and implantation metastasis model. The sTLR4/MD-2 complex treated mice had smaller tumor, less body weight loss and lower expression of inflammatory cytokines. Here, the azoxymethane/dextran sulfate sodium salt (AOM/DSS) murine model was used as an experimental platform to simulate the physiological and pathological processes of cancers associated with chronic intestinal inflammation. AOM/DSS-induced tumors were inhibited in mice treated by sTLR4/MD-2 complex. It is demonstrated in our study that sTLR4/MD-2 complex could inhibit CRC by competing with binding LPS, raising the complex's possibility of a new prevention agent against CRC.</AbstractText>
            </Abstract>
            <AuthorList CompleteYN="Y">
                <Author ValidYN="Y">
                    <LastName>Zou</LastName>
                    <ForeName>Yan</ForeName>
                    <Initials>Y</Initials>
                    <AffiliationInfo>
                        <Affiliation>Medical Science Laboratory, The Fourth Affiliated Hospital of Guangxi Medical University, Liuzhou, Guangxi, 545005, P.R. China.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Qin</LastName>
                    <ForeName>Fengxian</ForeName>
                    <Initials>F</Initials>
                    <AffiliationInfo>
                        <Affiliation>Medical Science Laboratory, The Fourth Affiliated Hospital of Guangxi Medical University, Liuzhou, Guangxi, 545005, P.R. China.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Chen</LastName>
                    <ForeName>Jifei</ForeName>
                    <Initials>J</Initials>
                    <AffiliationInfo>
                        <Affiliation>Medical Science Laboratory, The Fourth Affiliated Hospital of Guangxi Medical University, Liuzhou, Guangxi, 545005, P.R. China.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Meng</LastName>
                    <ForeName>Jie</ForeName>
                    <Initials>J</Initials>
                    <AffiliationInfo>
                        <Affiliation>Medical Science Laboratory, The Fourth Affiliated Hospital of Guangxi Medical University, Liuzhou, Guangxi, 545005, P.R. China.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Wei</LastName>
                    <ForeName>Liuhua</ForeName>
                    <Initials>L</Initials>
                    <AffiliationInfo>
                        <Affiliation>Medical Science Laboratory, The Fourth Affiliated Hospital of Guangxi Medical University, Liuzhou, Guangxi, 545005, P.R. China.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Wu</LastName>
                    <ForeName>Chunlin</ForeName>
                    <Initials>C</Initials>
                    <AffiliationInfo>
                        <Affiliation>Medical Science Laboratory, The Fourth Affiliated Hospital of Guangxi Medical University, Liuzhou, Guangxi, 545005, P.R. China.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Zhang</LastName>
                    <ForeName>Qiaoyun</ForeName>
                    <Initials>Q</Initials>
                    <AffiliationInfo>
                        <Affiliation>Medical Science Laboratory, The Fourth Affiliated Hospital of Guangxi Medical University, Liuzhou, Guangxi, 545005, P.R. China.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Wei</LastName>
                    <ForeName>Dong</ForeName>
                    <Initials>D</Initials>
                    <AffiliationInfo>
                        <Affiliation>Medical Science Laboratory, The Fourth Affiliated Hospital of Guangxi Medical University, Liuzhou, Guangxi, 545005, P.R. China.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Chen</LastName>
                    <ForeName>Xiang</ForeName>
                    <Initials>X</Initials>
                    <AffiliationInfo>
                        <Affiliation>Medical Science Laboratory, The Fourth Affiliated Hospital of Guangxi Medical University, Liuzhou, Guangxi, 545005, P.R. China.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Wu</LastName>
                    <ForeName>Hao</ForeName>
                    <Initials>H</Initials>
                    <AffiliationInfo>
                        <Affiliation>Medical Science Laboratory, The Fourth Affiliated Hospital of Guangxi Medical University, Liuzhou, Guangxi, 545005, P.R. China.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Chen</LastName>
                    <ForeName>Xiaoli</ForeName>
                    <Initials>X</Initials>
                    <AffiliationInfo>
                        <Affiliation>Medical Science Laboratory, The Fourth Affiliated Hospital of Guangxi Medical University, Liuzhou, Guangxi, 545005, P.R. China.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Dai</LastName>
                    <ForeName>Shengming</ForeName>
                    <Initials>S</Initials>
                    <AffiliationInfo>
                        <Affiliation>Medical Science Laboratory, The Fourth Affiliated Hospital of Guangxi Medical University, Liuzhou, Guangxi, 545005, P.R. China.</Affiliation>
                    </AffiliationInfo>
                </Author>
            </AuthorList>
            <Language>eng</Language>
            <PublicationTypeList>
                <PublicationType UI="D016428">Journal Article</PublicationType>
            </PublicationTypeList>
        </Article>
        <MedlineJournalInfo>
            <Country>United States</Country>
            <MedlineTA>Oncotarget</MedlineTA>
            <NlmUniqueID>101532965</NlmUniqueID>
            <ISSNLinking>1949-2553</ISSNLinking>
        </MedlineJournalInfo>
        <ChemicalList>
            <Chemical>
                <RegistryNumber>0</RegistryNumber>
                <NameOfSubstance UI="D000970">Antineoplastic Agents</NameOfSubstance>
            </Chemical>
            <Chemical>
                <RegistryNumber>0</RegistryNumber>
                <NameOfSubstance UI="D008070">Lipopolysaccharides</NameOfSubstance>
            </Chemical>
            <Chemical>
                <RegistryNumber>0</RegistryNumber>
                <NameOfSubstance UI="D051218">Lymphocyte Antigen 96</NameOfSubstance>
            </Chemical>
            <Chemical>
                <RegistryNumber>0</RegistryNumber>
                <NameOfSubstance UI="D051197">Toll-Like Receptor 4</NameOfSubstance>
            </Chemical>
        </ChemicalList>
        <CitationSubset>IM</CitationSubset>
        <MeshHeadingList>
            <MeshHeading>
                <DescriptorName UI="D000818" MajorTopicYN="N">Animals</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D000970" MajorTopicYN="N">Antineoplastic Agents</DescriptorName>
                <QualifierName UI="Q000494" MajorTopicYN="Y">pharmacology</QualifierName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D045744" MajorTopicYN="N">Cell Line, Tumor</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D015179" MajorTopicYN="N">Colorectal Neoplasms</DescriptorName>
                <QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName>
                <QualifierName UI="Q000473" MajorTopicYN="Y">pathology</QualifierName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D008070" MajorTopicYN="N">Lipopolysaccharides</DescriptorName>
                <QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D051218" MajorTopicYN="N">Lymphocyte Antigen 96</DescriptorName>
                <QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName>
                <QualifierName UI="Q000494" MajorTopicYN="N">pharmacology</QualifierName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D051379" MajorTopicYN="N">Mice</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D015398" MajorTopicYN="N">Signal Transduction</DescriptorName>
                <QualifierName UI="Q000502" MajorTopicYN="N">physiology</QualifierName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D051197" MajorTopicYN="N">Toll-Like Receptor 4</DescriptorName>
                <QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName>
            </MeshHeading>
        </MeshHeadingList>
        <KeywordList Owner="NOTNLM">
            <Keyword MajorTopicYN="N">CRC</Keyword>
            <Keyword MajorTopicYN="N">LPS</Keyword>
            <Keyword MajorTopicYN="N">migration cytokine</Keyword>
            <Keyword MajorTopicYN="N">pro-inflammatory cytokine</Keyword>
            <Keyword MajorTopicYN="N">sTLR4/MD-2 complex</Keyword>
        </KeywordList>
        <CoiStatement>The authors declare no competing financial interests.</CoiStatement>
    </MedlineCitation>
    <PubmedData>
        <History>
            <PubMedPubDate PubStatus="received">
                <Year>2016</Year>
                <Month>02</Month>
                <Day>23</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="accepted">
                <Year>2016</Year>
                <Month>06</Month>
                <Day>30</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="pubmed">
                <Year>2016</Year>
                <Month>7</Month>
                <Day>14</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="medline">
                <Year>2018</Year>
                <Month>1</Month>
                <Day>13</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="entrez">
                <Year>2016</Year>
                <Month>7</Month>
                <Day>14</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
        </History>
        <PublicationStatus>ppublish</PublicationStatus>
        <ArticleIdList>
            <ArticleId IdType="pubmed">27409669</ArticleId>
            <ArticleId IdType="pii">10496</ArticleId>
            <ArticleId IdType="doi">10.18632/oncotarget.10496</ArticleId>
            <ArticleId IdType="pmc">PMC5239533</ArticleId>
        </ArticleIdList>
        <ReferenceList>
            <Reference>
                <Citation>World J Gastroenterol. 2014 Mar 21;20(11):2979-94</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">24659889</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Innate Immun. 2011 Aug;17(4):414-22</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">20699280</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Science. 2007 Jul 6;317(5834):121-4</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">17615358</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>J Transl Med. 2010 Nov 08;8:112</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">21059221</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>JAMA. 2013 Mar 20;309(11):1154-62</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">23512062</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Nature. 2004 Sep 23;431(7007):405-6</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">15385993</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Cell Mol Immunol. 2011 May;8(3):265-75</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">21383675</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>J Immunol. 2015 Oct 1;195(7):3110-8</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">26324776</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>CA Cancer J Clin. 2010 Sep-Oct;60(5):277-300</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">20610543</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>J Gastroenterol. 2012 Feb;47(2):97-106</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">22218775</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Mol Immunol. 2007 Apr;44(11):2850-9</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">17328955</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>J Immunol. 2005 Nov 15;175(10):6465-72</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">16272300</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Cancer Res. 2006 Apr 1;66(7):3859-68</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">16585214</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Chin J Cancer Res. 2015 Feb;27(1):2-12</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">25717220</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Int J Biol Sci. 2010 Nov 03;6(7):675-81</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">21060729</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Oncotarget. 2015 Dec 1;6(38):41237-57</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">26517809</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Br J Cancer. 2010 Mar 2;102(5):908-15</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">20145615</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Cancer Res. 2005 Jun 15;65(12):5009-14</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">15958541</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Oncogene. 2008 Jan 7;27(2):218-24</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">18176603</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Gastroenterology. 2007 Dec;133(6):1869-81</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">18054559</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Nat Med. 2007 Dec;13(12):1458-66</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">18059280</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Mol Immunol. 2015 Feb;63(2):134-42</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">25037631</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Mol Immunol. 2004 Feb;40(12):861-8</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">14698224</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>BMC Cancer. 2013 Jun 26;13:311</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">23803172</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Nature. 2009 Apr 30;458(7242):1191-5</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">19252480</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Eur J Cancer. 2010 Oct;46(15):2849-57</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">20728343</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Nat Immunol. 2005 Jun;6(6):565-70</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">15895089</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Nat Rev Immunol. 2004 Jul;4(7):499-511</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">15229469</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Am J Med Sci. 2010 Apr;339(4):319-26</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">20228668</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Curr Opin Immunol. 2000 Feb;12(1):20-6</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">10679411</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Trends Immunol. 2012 Sep;33(9):449-58</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">22721918</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Clin Cancer Res. 2005 Oct 15;11(20):7554-63</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">16243831</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Cell. 2007 Sep 7;130(5):906-17</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">17803912</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Annu Rev Biochem. 2007;76:141-65</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">17362201</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Expert Opin Drug Metab Toxicol. 2011 Apr;7(4):479-94</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">21323610</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Cancer Immunol Immunother. 2012 Jan;61(1):71-7</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">21845432</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>PLoS One. 2011;6(12):e27399</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">22180778</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Clin Cancer Res. 2009 Jun 15;15(12 ):4114-22</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">19470740</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Chem Biol Interact. 2009 Nov 10;182(1):59-66</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">19627980</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>J Immunol. 2006 May 15;176(10):6211-8</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">16670331</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Drug Discov Today. 2014 Apr;19(4):379-82</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">24012797</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Zhonghua Wei Chang Wai Ke Za Zhi. 2015 Feb;18(2):177-80</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">25656129</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
    </PubmedData>
</PubmedArticle>

</PubmedArticleSet>